• Events Calendar
  • Drug Discovery
    • Targets & Screening
    • Pre-Clinical & Translational Development
    • Drug Design & Medical Chemistry
    • AI & Automation
  • Drug Development
    • Large Molecule Formation
    • Large Molecule Delivery
    • Small Molecule Formulation
    • Small Molecule Delivery
    • RNA Design & Delivery
  • Therapeutics
    • Neuro & Neuroimmunology
    • ADC-Based
    • News
    • Market Insight
    • Thought Leadership
    • Technology Spotlight
Register Sign In
  • Events Calendar
  • Drug Discovery
      Targets & Screening
      Pre-Clinical & Translational Development
      Drug Design & Medical Chemistry
      AI & Automation
  • Drug Development
      Large Molecule Formation
      Large Molecule Delivery
      Small Molecule Formulation
      Small Molecule Delivery
      RNA Design & Delivery
  • Therapeutics
      Neuro & Neuroimmunology
      ADC-Based
  • Format
      News
      Market Insight
      Thought Leadership
      Technology Spotlight
    Search
Sign In
Thought Leadership Drug Development Small Molecule Delivery |

Executive Interview with David Loynd, EnduRx Pharmaceuticals

On-Demand
September 4, 2025
|
00:00 UK Time
|
Event lasts 19m
David Loynd

David Loynd

Chief Executive Officer

EnduRx Pharmaceuticals

Format: 19 minute interview

Register free to attend thought leadership

Do you have a question you’d like David Loynd to answer during the session?

Register and ask
Related posts
Executive Interview with Shilpa Thosar, Former Executive Director, Cara Therapeutics

Executive Interview with Shilpa Thosar, Former Executive Director, Cara Therapeutics

Shilpa Thosar
Drug Development
Sep, 2025
Executive Interview with David Loynd, EnduRx Pharmaceuticals

Executive Interview with David Loynd, EnduRx Pharmaceuticals

David Loynd EnduRx Pharmaceuticals
Drug Development
Sep, 2025
Executive Interview with Jean Ge, Wolf Greenfield

Executive Interview with Jean Ge, Wolf Greenfield

Jean Ge Wolf Greenfield
Drug Development
Sep, 2025
Upcoming events
12
Nov
Unlocking the Promise of Protein Degraders: Molecular Glues, PROTACs, and the Path Forward

Online

Join Stefan Schiesser the Director of Medicinal Chemistry at AstraZeneca to discuss unlocking the promise of protein degraders: molecular glues, PROTACs and the path forward.

02
Mar
Advancing Formulation Development

Online

This tech showcase will spotlight cutting-edge approaches to enhancing solubility and bioavailability, including predictive modeling, data-driven formulation design, and innovative delivery systems. Attendees will see these technologies in action and engage in a live discussion with industry experts to uncover real-world applications and address formulation challenges.

Register for free to view

  • Quickly grasp the key takeaways from cutting-edge biomed research with our bite-sized 5-minute video summaries, before diving into the full presentations from leaders in the industry.

  • From cutting-edge discoveries to real-world applications, see how new research can impact your work, from the lab to commercialisation.

  • Join a community of next-gen scientists, academics and researchers, stay connected, and engage with the latest innovations shaping the future of biomedicine.

Register Free

Already registered? Sign In.

  • Events
    About Us
    Contact Us
    FAQ
    Privacy Policy
    Terms of Use
    Cookie Policy
  • Drug Discovery
    Drug Development
    Therapeutics
  • Discovery & Development
    NextGen Biomed
    Precision Medicine
    Oxford Global
© 2025 Oxford Global Ltd. All rights reserved.
Designed & built by Standfirst

You're just a click away

To access our site, please accept the Terms of Use - our full terms of use are available below.
Full Terms of Use

By rejecting you won't be able to progress to the LifeScienceXchange platform.